Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,286 USD | -4,67% | -14,63% | -31,25% |
Omzet 2024 * | 7,3 mln. 5,3 mln. 4,98 mln. | Omzet 2025 * | 9,12 mln. 6,62 mln. 6,22 mln. | Marktkapitalisatie | 2,51 mln. 1,82 mln. 1,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,34 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,27 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 13 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,64% |
Recentste transcriptie over InMed Pharmaceuticals Inc.
1 dag | -4,67% | ||
1 week | -14,63% | ||
Lopende maand | -21,43% | ||
1 maand | -19,46% | ||
3 maanden | -19,44% | ||
6 maanden | -53,77% | ||
Lopend jaar | -31,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Chief Operating Officer | - | 05-11-18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11-02-22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Andrew Hull
CHM | Chairman | 61 | 12-09-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,286 | -4,67% | 100 585 |
17-04-24 | 0,3 | -1,78% | 260 209 |
16-04-24 | 0,3054 | -4,16% | 806 885 |
15-04-24 | 0,3187 | -3,28% | 103 193 |
12-04-24 | 0,3295 | -1,64% | 67 463 |
uitgestelde koers Nasdaq, 18 april 2024 om 19:08 uur
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-31,25% | 1,82 mln. | |
-3,43% | 102 mld. | |
+2,15% | 96,84 mld. | |
-0,44% | 21,48 mld. | |
-18,56% | 20,82 mld. | |
-7,45% | 18,6 mld. | |
-40,31% | 16,81 mld. | |
-26,16% | 13,78 mld. | |
+0,54% | 13,4 mld. | |
+20,20% | 11,06 mld. |